Preliminary report on the treatment of nonresectable cancer of the lung.
D000230:Adenocarcinoma / Q000628:therapy; D000577:Amides / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004123:Dimethylamines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008936:Mitolactol / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D013311:Streptozocin / Q000627:therapeutic use; D013997:Time Factors; D014226:Triazenes / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use
D000577:Amides; D000970:Antineoplastic Agents; D004123:Dimethylamines; D007093:Imidazoles; D009607:Nitrosourea Compounds; D014226:Triazenes; D014227:Triazines; D011344:Procarbazine; D013311:Streptozocin; D003520:Cyclophosphamide; D001215:Asparaginase; D008936:Mitolactol